Explore › Condition › Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome
Condition

Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome

Also known as: Cystic fibrosis screen positive, inconclusive diagnosis Cystic fibrosis transmembrane conductance regulator related metabolic syndrome Cystic fibrosis transmembrane conductance regulator related metabolic syndrome (finding) Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome (finding) metabolic syndrome; glucose metabolic dysregulation
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
Targeted glucose and metabolic screening1
outcomes
Glucose Metabolism Disorders1
populations
Postmenopausal Women1
studys
PMC30744071

Findings (27)

None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →
None
decline

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85
PMC3074407
Finding details → · Paper → · Graph →

Papers (1)